Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Suppression of cancer cell growth by promoting cyclin D1 degradation.

Molecular cell | Nov 13, 2009

The cyclin D1 proto-oncoprotein is a crucial regulator in cell-cycle progression, and aberrant overexpression of cyclin D1 is linked to tumorigenesis of many different cancer types. By screening ubiquitinated cyclin D1 as a substrate with a deubiquitinase library, we have identified USP2 as a specific deubiquitinase for cyclin D1. USP2 directly interacts with cyclin D1 and promotes its stabilization by antagonizing ubiquitin-dependent degradation. Conversely, USP2 knockdown destabilizes cyclin D1 and induces growth arrest in the human cancer lines where cell growth is dependent on cyclin D1 expression. Of note, cyclin D1 is not universally required for cell-cycle progression. Inactivation of USP2 has either very mild effects on cell growth in normal human fibroblasts or no effect in the cancer cells that do not express cyclin D1. These findings suggest that targeting USP2 is an effective approach to induce growth suppression in the cancer cells addicted to cyclin D1 expression.

Pubmed ID: 19917254 RIS Download

Mesh terms: Blotting, Western | Cell Cycle | Cell Line | Cell Line, Tumor | Cell Proliferation | Cyclin D1 | Endopeptidases | Flow Cytometry | HCT116 Cells | Humans | Neoplasms | RNA, Small Interfering | Reverse Transcriptase Polymerase Chain Reaction | Transfection | Tumor Suppressor Protein p53 | Ubiquitin | Ubiquitination

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: P01 CA097403
  • Agency: NCI NIH HHS, Id: R01 CA129627-03
  • Agency: NCI NIH HHS, Id: R01 CA085533
  • Agency: NCI NIH HHS, Id: R01 CA104843
  • Agency: NCI NIH HHS, Id: P01 CA080058
  • Agency: NCI NIH HHS, Id: R01 CA129627

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.